Research at Taizhou Enze Medical Center in China focused on the risk priority of adverse events during all phases of ...

Multiple sclerosis (MS) is a chronic autoimmune disorder affecting the central nervous system, often emerging in early adulthood and representing a leading cause of neurological disability in young ...

Abbott Laboratories will make new investments in US manufacturing, with the impact of tariffs on medical devices and diagnostics looming over the industry. It expects to spend $500 million on two ...

Custom-made Cancer Therapy: Neoantigen Vaccines Immuno-oncologists at UCSD and La Jolla Institute discuss approaches to cancer vaccines that target tumor-specific neoantigens unique to each ...

Caplin Point Laboratories Limited is an India-based pharmaceutical company with a business model catering predominantly to emerging markets of Latin America and Africa. The Company has also ...

Apr. 15, 2025 — Researchers have demonstrated a way to use corn protein to improve the performance of lithium-sulfur batteries, a finding that holds promise for expanding the use of the high ...

Cite this: The Role of C-Reactive Protein in the Evaluation and Management of Infants With Suspected Sepsis - Medscape - Feb 01, 2003. Infection The body's response to the invasion of any ...

Blood tests can help a doctor diagnose a variety of health conditions, including infections, anemia, high cholesterol, vitamin deficiencies, organ failure, HIV, cancer, and diabetes. Doctors use ...

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

which is expected to launch in the U.S. in 2025 through Trinity’s Immco reference lab. This strategic acquisition enhances Trinity’s diagnostics platform with advanced machine learning and ...

Over my forty years or so in and around dealing rooms and financial markets, I have heard many theories as to how to approach that problem and have settled on a process that has worked for me ...